findmyKOL
Clinical trialNCT02684578CompletedPhase 2Interventional

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

SponsorUniversity of California, San FranciscoEnrollment66Age-Related Macular DegenerationDry Macular DegenerationGeographic AtrophyMacular Degeneration, Age-Related
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, Davis

    Davis, California, United States

  • Palo Alto Veteran Affairs Medical Center

    Palo Alto, California, United States

  • Retinal Consultants Medical Group

    Sacramento, California, United States

  • San Francisco Veteran Affairs Medical Center

    San Francisco, California, United States

  • University of California San Francisco

    San Francisco, California, United States

  • California Retina Consultants

    Santa Maria, California, United States

  • North Bay Vitreoretinal Consultants

    Santa Rosa, California, United States

  • Retina Health Center

    Fort Myers, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • University of Illinois at Chicago

    Chicago, Illinois, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • Austin Retina Associates

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2016
Primary completion
30 Apr 2022
Completion
31 Oct 2022
Last update posted
9 Jun 2023
Registered enrollment
66
Registry id
NCT02684578

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.